# Immune Reconstitution in Tuberculosis Disease

> **NCT01698476** · PHASE2 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 390 (actual)

## Conditions studied

- Pulmonary Tuberculosis (TB)

## Interventions

- **DRUG:** vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate)
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT01698476
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2016-02-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698476, "Immune Reconstitution in Tuberculosis Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01698476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*